The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Increase Is Anticipated For The Breast Biopsy Market Over The 2026–2030 Period?
The breast biopsy market has experienced substantial expansion in recent times. It is projected to increase from $1.53 billion in 2025 to $1.65 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.5%. This historical growth can be attributed to several factors, including the limited availability of advanced biopsy systems, a reliance on traditional surgical biopsy methods, the rising incidence of breast cancer, the expansion of hospital and diagnostic center infrastructure, and the adoption of ultrasound-guided procedures.
The breast biopsy market size is projected to undergo significant expansion in the foreseeable future. It is forecast to achieve a value of $2.17 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.2%. This projected growth over the forecast period stems from various factors such as technological progress in liquid biopsy and imaging-guided systems, an increased focus on early breast cancer detection, the proliferation of diagnostic centers and hospitals, the growing incorporation of AI and data analytics, and the evolution of personalized and precision medicine approaches. Prominent trends for this period include the wider acceptance of minimally invasive biopsy procedures, an increase in the application of liquid biopsy techniques, the development of imaging-guided biopsy systems, the expansion of breast cancer diagnostic and screening initiatives, and a stronger emphasis on patient safety and the accuracy of samples.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19348&type=smp
Which Economic Or Industry Drivers Are Impacting The Breast Biopsy Market?
The increasing prevalence of breast cancer is anticipated to drive the expansion of the breast biopsy market moving forward. Breast cancer is characterized as a malignant tumor forming in breast tissue cells, capable of spreading to other bodily parts if not promptly addressed. The widespread occurrence of breast cancer is linked to factors such as enhanced life expectancy, improved detection methodologies, and increased public awareness regarding the condition. A breast biopsy serves to collect tissue samples from suspicious areas within the breast, enabling the diagnosis and characterization of breast cancer. For instance, in October 2025, Breastcancer.org, a US-based non-profit organization, reported that in 2025, an estimated 316,950 women are projected to be diagnosed with invasive breast cancer, alongside approximately 59,080 new cases of non-invasive ductal carcinoma in situ (DCIS). Thus, the rising incidence of breast cancer is propelling the growth of the breast biopsy market.
How Is The Breast Biopsy Market Segmented Across Key Categories?
The breast biopsy market covered in this report is segmented –
1) By Type: Biopsy Needles, Guidance Systems, Biopsy Tables, Localization Wires, Assay Kits, Liquid Biopsy Instruments, Other Types
2) By Image Guided Technology: Magnetic Resonance Imaging (MRI) Guided Breast Biopsy, Ultrasound Guided Breast Biopsy, Mammography Guided Stereotactic Biopsy, Computed Tomography (CT) Guided Biopsy, Other Image Guided Technologies
3) By Procedure: Needle Breast Biopsy, Open Surgical Breast Biopsy, Liquid Breast Biopsy
4) By Application: Hospitals, Clinics, Diagnostic Centers, Other Applications
Subsegments:
1) By Biopsy Needles: Core Biopsy Needles, Fine Needle Aspiration (FNA) Needles, Vacuum-Assisted Biopsy Needles, Automatic Biopsy Needles
2) By Guidance Systems: Ultrasound Guidance Systems, MRI Guidance Systems, Stereotactic Guidance Systems, Tomosynthesis Guidance Systems
3) By Biopsy Tables: Adjustable Biopsy Tables, Specialty Biopsy Tables, Imaging-Compatible Biopsy Tables
4) By Localization Wires: Hookwire Localization Devices, Radioguided Localization Wires, Magnetic Seed Localization Systems
5) By Assay Kits: Breast Cancer Assay Kits, Biomarker Detection Kits, Genetic Testing Kits for Breast Cancer
6) By Liquid Biopsy Instruments: Circulating Tumor Cell (CTC) Isolation Devices, Plasma DNA Isolation Kits, Liquid Biopsy Analysis Systems
7) By Other Types: Biopsy Adhesives, Specimen Collection and Transport Devices, Patient Management Systems
Which Upcoming Trends Are Expected To Influence The Breast Biopsy Market?
Leading companies operating in the breast biopsy marker market are concentrating on developing innovative products, such as ultrasound-visible site markers, to enhance lesion localization and reduce marker displacement during breast biopsy procedures. An ultrasound-visible site marker is a specially designed implantable device that improves the visualization of biopsy sites during imaging and provides stable localization for future surgical intervention. For instance, in August 2023, Mammotome, a US-based provider of breast biopsy and localization technologies, launched HydroMark Plus. This new breast biopsy site marker offers improved lesion visibility on ultrasound, which assists radiologists and surgeons in accurately targeting biopsy sites while reducing the risk of marker displacement during subsequent surgical procedures. As the latest addition to Mammotome’s HydroMark portfolio, HydroMark Plus is designed for enhanced procedural reliability and is slated for nationwide availability in the U.S. by the end of the year. The product’s key features include high ultrasound conspicuity for easy detection, a minimized risk of movement within breast tissue, and suitability for a wide variety of breast imaging and interventional workflows. These attributes are aimed at improving clinical outcomes and procedural confidence for both physicians and patients.
Who Are The Dominant Players Shaping The Breast Biopsy Market Landscape?
Major companies operating in the breast biopsy market are Siemens Healthineers AG, Fujifilm Holdings Corporation, Becton Dickinson and Company BD, Koninklijke Philips, GE HealthCare Technologies Inc, Hologic Inc, Merit Medical Systems, Argon Medical Devices, Canon Medical Systems Corporation, Devicor Medical Products Inc, Planmed Oy, Menarini-Silicon Biosystems, Seno Medical Instruments Inc, Dilon Technologies Inc, INRAD Inc, Promaxo Inc, Cook Medical LLC, Boston Scientific Corporation, Stryker Corporation, Intact Medical Corporation, Scion Medical Technologies LLC, Galini SRL, Ethicon Surgical Technologies, Encapsule Medical Devices LLC, Cardinal Health Inc, Olympus Corporation, F Hoffmann-La Roche Ltd, Biocept Inc.
Read the full breast biopsy market report here:
https://www.thebusinessresearchcompany.com/report/breast-biopsy-global-market-report
What Are The Top-Performing Regions Within The Breast Biopsy Market?
North America was the largest region in the breast biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the breast biopsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Breast Biopsy Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=19348&type=smp
Browse Through More Reports Similar to the Global Breast Biopsy Market 2026, By The Business Research Company
Biopsy Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report
Liquid Biopsy For Cancer Diagnostics Market Report 2026
Smart Biopsy Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/smart-biopsy-devices-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
